Abstract
The constitutive activation of RAS proteins is closely linked with the aggressiveness of cancer cells. Although RAS proteins are effective targets for cancer therapy, the development of drugs targeting RAS proteins has been unsuccessful so far due to the absence of a suitable active site for small molecule drugs. RAS mRNA that forms a Gquadruplex (G4) in the 5′-untranslated region (UTR) has been deemed as a druggable target. In this study, we demonstrated the advantages of photodynamic therapy (PDT) for the treatment of cancer using G4 ligands targeting RAS mRNA, including our previously reported ligand anionic phthalocyanine ZnAPC.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.